Global ADHD Therapeutics Market Size, Status and Forecast 2020-2026

May 2020 | 98 pages | ID: G7D1B98E78AAEN
QYResearch

Abstracts

This report focuses on the global ADHD Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the ADHD Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Eli Lilly
• Novartis
• Takeda
• Pfizer
• GlaxoSmithKline
• Mallinckrodt Pharmaceuticals
• Hisamitsu Pharmaceutical
• Impax Laboratories
• Johnson & Johnson
• UCB S.A.
• Purdue Parma

Market segment by Type, the product can be split into

• Stimulants
• Non-stimulants

Market segment by Application, split into

• Specialty Clinics
• Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global ADHD Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the ADHD Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of ADHD Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by ADHD Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global ADHD Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Stimulants
  1.4.3 Non-stimulants
1.5 Market by Application
  1.5.1 Global ADHD Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Specialty Clinics
  1.5.3 Hospital Pharmacies
  1.5.4 Retail Pharmacies
  1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 ADHD Therapeutics Market Perspective (2015-2026)
2.2 ADHD Therapeutics Growth Trends by Regions
  2.2.1 ADHD Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 ADHD Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 ADHD Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 ADHD Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key ADHD Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top ADHD Therapeutics Players by Market Size
  3.1.1 Global Top ADHD Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global ADHD Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global ADHD Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global ADHD Therapeutics Market Concentration Ratio
  3.2.1 Global ADHD Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by ADHD Therapeutics Revenue in 2019
3.3 ADHD Therapeutics Key Players Head office and Area Served
3.4 Key Players ADHD Therapeutics Product Solution and Service
3.5 Date of Enter into ADHD Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global ADHD Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global ADHD Therapeutics Forecasted Market Size by Type (2021-2026)

5 ADHD THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global ADHD Therapeutics Market Size by Application (2015-2020)
5.2 Global ADHD Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America ADHD Therapeutics Market Size (2015-2020)
6.2 ADHD Therapeutics Key Players in North America (2019-2020)
6.3 North America ADHD Therapeutics Market Size by Type (2015-2020)
6.4 North America ADHD Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe ADHD Therapeutics Market Size (2015-2020)
7.2 ADHD Therapeutics Key Players in Europe (2019-2020)
7.3 Europe ADHD Therapeutics Market Size by Type (2015-2020)
7.4 Europe ADHD Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China ADHD Therapeutics Market Size (2015-2020)
8.2 ADHD Therapeutics Key Players in China (2019-2020)
8.3 China ADHD Therapeutics Market Size by Type (2015-2020)
8.4 China ADHD Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan ADHD Therapeutics Market Size (2015-2020)
9.2 ADHD Therapeutics Key Players in Japan (2019-2020)
9.3 Japan ADHD Therapeutics Market Size by Type (2015-2020)
9.4 Japan ADHD Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia ADHD Therapeutics Market Size (2015-2020)
10.2 ADHD Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia ADHD Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia ADHD Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India ADHD Therapeutics Market Size (2015-2020)
11.2 ADHD Therapeutics Key Players in India (2019-2020)
11.3 India ADHD Therapeutics Market Size by Type (2015-2020)
11.4 India ADHD Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America ADHD Therapeutics Market Size (2015-2020)
12.2 ADHD Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America ADHD Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America ADHD Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Eli Lilly
  13.1.1 Eli Lilly Company Details
  13.1.2 Eli Lilly Business Overview and Its Total Revenue
  13.1.3 Eli Lilly ADHD Therapeutics Introduction
  13.1.4 Eli Lilly Revenue in ADHD Therapeutics Business (2015-2020))
  13.1.5 Eli Lilly Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis ADHD Therapeutics Introduction
  13.2.4 Novartis Revenue in ADHD Therapeutics Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Takeda
  13.3.1 Takeda Company Details
  13.3.2 Takeda Business Overview and Its Total Revenue
  13.3.3 Takeda ADHD Therapeutics Introduction
  13.3.4 Takeda Revenue in ADHD Therapeutics Business (2015-2020)
  13.3.5 Takeda Recent Development
13.4 Pfizer
  13.4.1 Pfizer Company Details
  13.4.2 Pfizer Business Overview and Its Total Revenue
  13.4.3 Pfizer ADHD Therapeutics Introduction
  13.4.4 Pfizer Revenue in ADHD Therapeutics Business (2015-2020)
  13.4.5 Pfizer Recent Development
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Details
  13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.5.3 GlaxoSmithKline ADHD Therapeutics Introduction
  13.5.4 GlaxoSmithKline Revenue in ADHD Therapeutics Business (2015-2020)
  13.5.5 GlaxoSmithKline Recent Development
13.6 Mallinckrodt Pharmaceuticals
  13.6.1 Mallinckrodt Pharmaceuticals Company Details
  13.6.2 Mallinckrodt Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Mallinckrodt Pharmaceuticals ADHD Therapeutics Introduction
  13.6.4 Mallinckrodt Pharmaceuticals Revenue in ADHD Therapeutics Business (2015-2020)
  13.6.5 Mallinckrodt Pharmaceuticals Recent Development
13.7 Hisamitsu Pharmaceutical
  13.7.1 Hisamitsu Pharmaceutical Company Details
  13.7.2 Hisamitsu Pharmaceutical Business Overview and Its Total Revenue
  13.7.3 Hisamitsu Pharmaceutical ADHD Therapeutics Introduction
  13.7.4 Hisamitsu Pharmaceutical Revenue in ADHD Therapeutics Business (2015-2020)
  13.7.5 Hisamitsu Pharmaceutical Recent Development
13.8 Impax Laboratories
  13.8.1 Impax Laboratories Company Details
  13.8.2 Impax Laboratories Business Overview and Its Total Revenue
  13.8.3 Impax Laboratories ADHD Therapeutics Introduction
  13.8.4 Impax Laboratories Revenue in ADHD Therapeutics Business (2015-2020)
  13.8.5 Impax Laboratories Recent Development
13.9 Johnson & Johnson
  13.9.1 Johnson & Johnson Company Details
  13.9.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.9.3 Johnson & Johnson ADHD Therapeutics Introduction
  13.9.4 Johnson & Johnson Revenue in ADHD Therapeutics Business (2015-2020)
  13.9.5 Johnson & Johnson Recent Development
13.10 UCB S.A.
  13.10.1 UCB S.A. Company Details
  13.10.2 UCB S.A. Business Overview and Its Total Revenue
  13.10.3 UCB S.A. ADHD Therapeutics Introduction
  13.10.4 UCB S.A. Revenue in ADHD Therapeutics Business (2015-2020)
  13.10.5 UCB S.A. Recent Development
13.11 Purdue Parma
  10.11.1 Purdue Parma Company Details
  10.11.2 Purdue Parma Business Overview and Its Total Revenue
  10.11.3 Purdue Parma ADHD Therapeutics Introduction
  10.11.4 Purdue Parma Revenue in ADHD Therapeutics Business (2015-2020)
  10.11.5 Purdue Parma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. ADHD Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by ADHD Therapeutics Revenue
Table 3. Ranking of Global Top ADHD Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global ADHD Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Stimulants
Table 6. Key Players of Non-stimulants
Table 7. Global ADHD Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global ADHD Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global ADHD Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global ADHD Therapeutics Market Share by Regions (2015-2020)
Table 11. Global ADHD Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global ADHD Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. ADHD Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key ADHD Therapeutics Players
Table 18. Global ADHD Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global ADHD Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top ADHD Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ADHD Therapeutics as of 2019)
Table 21. Global ADHD Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players ADHD Therapeutics Product Solution and Service
Table 24. Date of Enter into ADHD Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global ADHD Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global ADHD Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global ADHD Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global ADHD Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global ADHD Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global ADHD Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players ADHD Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players ADHD Therapeutics Market Share (2019-2020)
Table 34. North America ADHD Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America ADHD Therapeutics Market Share by Type (2015-2020)
Table 36. North America ADHD Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America ADHD Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players ADHD Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players ADHD Therapeutics Market Share (2019-2020)
Table 40. Europe ADHD Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe ADHD Therapeutics Market Share by Type (2015-2020)
Table 42. Europe ADHD Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe ADHD Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players ADHD Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players ADHD Therapeutics Market Share (2019-2020)
Table 46. China ADHD Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China ADHD Therapeutics Market Share by Type (2015-2020)
Table 48. China ADHD Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China ADHD Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players ADHD Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players ADHD Therapeutics Market Share (2019-2020)
Table 52. Japan ADHD Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan ADHD Therapeutics Market Share by Type (2015-2020)
Table 54. Japan ADHD Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan ADHD Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players ADHD Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players ADHD Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia ADHD Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia ADHD Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia ADHD Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia ADHD Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players ADHD Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players ADHD Therapeutics Market Share (2019-2020)
Table 64. India ADHD Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India ADHD Therapeutics Market Share by Type (2015-2020)
Table 66. India ADHD Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India ADHD Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players ADHD Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players ADHD Therapeutics Market Share (2019-2020)
Table 70. Central & South America ADHD Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America ADHD Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America ADHD Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America ADHD Therapeutics Market Share by Application (2015-2020)
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Product
Table 77. Eli Lilly Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 78. Eli Lilly Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Takeda Company Details
Table 85. Takeda Business Overview
Table 86. Takeda Product
Table 87. Takeda Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 88. Takeda Recent Development
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Product
Table 92. Pfizer Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 93. Pfizer Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Product
Table 97. GlaxoSmithKline Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline Recent Development
Table 99. Mallinckrodt Pharmaceuticals Company Details
Table 100. Mallinckrodt Pharmaceuticals Business Overview
Table 101. Mallinckrodt Pharmaceuticals Product
Table 102. Mallinckrodt Pharmaceuticals Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 103. Mallinckrodt Pharmaceuticals Recent Development
Table 104. Hisamitsu Pharmaceutical Company Details
Table 105. Hisamitsu Pharmaceutical Business Overview
Table 106. Hisamitsu Pharmaceutical Product
Table 107. Hisamitsu Pharmaceutical Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 108. Hisamitsu Pharmaceutical Recent Development
Table 109. Impax Laboratories Business Overview
Table 110. Impax Laboratories Product
Table 111. Impax Laboratories Company Details
Table 112. Impax Laboratories Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 113. Impax Laboratories Recent Development
Table 114. Johnson & Johnson Company Details
Table 115. Johnson & Johnson Business Overview
Table 116. Johnson & Johnson Product
Table 117. Johnson & Johnson Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 118. Johnson & Johnson Recent Development
Table 119. UCB S.A. Company Details
Table 120. UCB S.A. Business Overview
Table 121. UCB S.A. Product
Table 122. UCB S.A. Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 123. UCB S.A. Recent Development
Table 124. Purdue Parma Company Details
Table 125. Purdue Parma Business Overview
Table 126. Purdue Parma Product
Table 127. Purdue Parma Revenue in ADHD Therapeutics Business (2015-2020) (Million US$)
Table 128. Purdue Parma Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global ADHD Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Stimulants Features
Figure 3. Non-stimulants Features
Figure 4. Global ADHD Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Specialty Clinics Case Studies
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. E-Commerce Case Studies
Figure 9. ADHD Therapeutics Report Years Considered
Figure 10. Global ADHD Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global ADHD Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global ADHD Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global ADHD Therapeutics Market Share by Players in 2019
Figure 15. Global Top ADHD Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ADHD Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by ADHD Therapeutics Revenue in 2019
Figure 17. North America ADHD Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe ADHD Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China ADHD Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan ADHD Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia ADHD Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India ADHD Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America ADHD Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Eli Lilly Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novartis Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 28. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Takeda Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 30. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Pfizer Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 34. Mallinckrodt Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Mallinckrodt Pharmaceuticals Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 36. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Hisamitsu Pharmaceutical Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 38. Impax Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Impax Laboratories Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 40. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Johnson & Johnson Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 42. UCB S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. UCB S.A. Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 44. Purdue Parma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Purdue Parma Revenue Growth Rate in ADHD Therapeutics Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed